TROPION-Lung15: A phase III study of datopotamab deruxtecan (Dato-DXd) ± osimertinib vs platinum doublet chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and disease progression on prior osimertinib Meeting Abstract
| Authors: | Nadal, E.; Cheema, P. K.; Wu, Y. L.; Ahn, M. J.; Tanizaki, J.; Gharagoozloo, S.; Nizialek, E.; Shi, X.; van der Gronde, T.; Yu, H. A.; Tan, D. S. W. |
| Abstract Title: | TROPION-Lung15: A phase III study of datopotamab deruxtecan (Dato-DXd) ± osimertinib vs platinum doublet chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and disease progression on prior osimertinib |
| Meeting Title: | European Lung Cancer Congress (ELCC) 2025 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 20 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2025 Mar 26-29 |
| Meeting Location: | Paris, France |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2025-03-01 |
| Start Page: | S87 |
| End Page: | S88 |
| DOI: | 10.1016/s1556-0864(25)00319-3 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 124TiP -- Source: Cinahl |
